
-
Grand Canyon fire rages, one month on
-
Djokovic withdraws from ATP Cincinnati Masters
-
Brazil's Paixao promises 'big things' at Marseille unveiling
-
Shubman Gill: India's elegant captain
-
Trump says to name new labor statistics chief this week
-
England v India: Three talking points
-
Exceptional Nordic heatwave stumps tourists seeking shade
-
'Musical cocoon': Polish mountain town hosts Chopin fest
-
A 'Thinker' drowns in plastic garbage as UN treaty talks open
-
India's Siraj 'woke up believing' ahead of Test heroics
-
Israeli PM says to brief army on Gaza war plan
-
Frustrated Stokes refuses to blame Brook for England collapse
-
Moscow awaits 'important' Trump envoy visit before sanctions deadline
-
Schick extends Bayer Leverkusen contract until 2030
-
Tesla approves $29 bn in shares to Musk as court case rumbles on
-
Stocks rebound on US rate cut bets
-
Swiss eye 'more attractive' offer for Trump after tariff shock
-
Trump says will name new economics data official this week
-
Three things we learned from the Hungarian Grand Prix
-
Lions hooker Sheehan banned over Lynagh incident
-
Jordan sees tourism slump over Gaza war
-
China's Baidu to deploy robotaxis on rideshare app Lyft
-
Israel wants world attention on hostages held in Gaza
-
Pacific algae invade Algeria beaches, pushing humans and fish away
-
Siraj stars as India beat England by six runs in fifth-Test thriller
-
Stocks mostly rise as traders boost US rate cut bets
-
S.Africa eyes new markets after US tariffs: president
-
Trump envoy's visit will be 'important', Moscow says
-
BP makes largest oil, gas discovery in 25 years off Brazil
-
South Korea removing loudspeakers on border with North
-
Italy fines fast-fashion giant Shein for 'green' claims
-
Shares in UK banks jump after car loan court ruling
-
Beijing issues new storm warning after deadly floods
-
Most markets rise as traders US data boosts rate cut bets
-
17 heat records broken in Japan
-
Most markets rise as traders weigh tariffs, US jobs
-
Tycoon who brought F1 to Singapore pleads guilty in graft case
-
Australian police charge Chinese national with 'foreign interference'
-
Torrential rain in Taiwan kills four over past week
-
Rwanda bees being wiped out by pesticides
-
Tourism boom sparks backlash in historic heart of Athens
-
Doctors fight vaccine mistrust as Romania hit by measles outbreak
-
Fritz fights through to reach ATP Toronto Masters quarters
-
Trump confirms US envoy Witkoff to travel to Russia in coming week
-
Mighty Atom: how the A-bombs shaped Japanese arts
-
'Let's go fly a kite': Capturing wind for clean energy in Ireland
-
Pakistan beat West Indies by 13 runs to capture T20 series
-
80 years on, Korean survivors of WWII atomic bombs still suffer
-
Teenage kicks: McIntosh, 12-year-old Yu set to rule the pool at LA 2028
-
New Zealand former top cop charged over material showing child abuse and bestiality
CMSD | 1.18% | 23.63 | $ | |
SCU | 0% | 12.72 | $ | |
RELX | 0.73% | 51.97 | $ | |
RBGPF | 0.08% | 75 | $ | |
AZN | 0.86% | 74.59 | $ | |
CMSC | 0.87% | 23.07 | $ | |
SCS | 38.6% | 16.58 | $ | |
RYCEF | 2.07% | 14.5 | $ | |
GSK | 0.32% | 37.68 | $ | |
JRI | 0.76% | 13.2 | $ | |
BTI | 2.16% | 55.55 | $ | |
BP | 2.28% | 32.49 | $ | |
BCC | -0.77% | 82.71 | $ | |
RIO | 0.58% | 60 | $ | |
VOD | 0.72% | 11.04 | $ | |
NGG | 1.14% | 72.65 | $ | |
BCE | -1.12% | 23.31 | $ |

Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
M.AbuKhalil--SF-PST